Anticholinergic drugs and dementia risk: Using stem cell–based studies to complement pharmacoepidemiology
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Tiara A. Schwarze‐Taufiq, Inez K. A. Pranoto, Katherine Hui, Chizuru Kinoshita, Onchee Yu, Paul K. Crane, Shelly L. Gray, Jessica E. Young |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Differential Effects of Anticholinergic Medications in Patient hiPSC‐Derived Neurons
by: Tiara A. Schwarze‐Taufiq, et al.
Published: (2024)
by: Tiara A. Schwarze‐Taufiq, et al.
Published: (2024)
Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
by: Benjamin R. Underwood, et al.
Published: (2025)
by: Benjamin R. Underwood, et al.
Published: (2025)
Anti‐epileptic drug use and subsequent degenerative dementia occurrence
by: Naoki Ikegaya, et al.
Published: (2024)
by: Naoki Ikegaya, et al.
Published: (2024)
Vascular cognitive impairment and dementia drug‐development pipeline 2025
by: Ying Xu, et al.
Published: (2026)
by: Ying Xu, et al.
Published: (2026)
Genetically proxied IL‐6 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: A drug target Mendelian randomization study
by: Evangelos Pavlos Myserlis, et al.
Published: (2024)
by: Evangelos Pavlos Myserlis, et al.
Published: (2024)
The association of dementia risk symptoms and functional activity in adults with Down syndrome
by: Selena E. Washington, et al.
Published: (2024)
by: Selena E. Washington, et al.
Published: (2024)
Statin use and dementia risk: A systematic review and updated meta‐analysis
by: Fernando Luiz Westphal Filho, et al.
Published: (2025)
by: Fernando Luiz Westphal Filho, et al.
Published: (2025)
Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
by: Luke E. Stoeckel, et al.
Published: (2025)
by: Luke E. Stoeckel, et al.
Published: (2025)
Correction to “Polypharmacy and risk of dementia progression in older adults with mild cognitive impairment: A longitudinal cohort study”
Published: (2026)
Published: (2026)
Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study
by: Norma B. Coe, et al.
Published: (2026)
by: Norma B. Coe, et al.
Published: (2026)
Potential of low‐field MRI for increasing participation of Filipino Americans and underrepresented populations in Alzheimer's and dementia research
by: Mikkael Lamoca, et al.
Published: (2025)
by: Mikkael Lamoca, et al.
Published: (2025)
Electroencephalography‐based signatures of cognitive resilience in individuals with stable mild cognitive impairment despite carrying a high‐risk for progression to dementia
by: Chiara Pappalettera, et al.
Published: (2025)
by: Chiara Pappalettera, et al.
Published: (2025)
Sick sinus syndrome and high‐degree atrioventricular block in dementia with Lewy bodies and other dementia subtypes: A study of ≈ 73,000 patients with dementia
by: Isak Heyman, et al.
Published: (2025)
by: Isak Heyman, et al.
Published: (2025)
The momentum for dementia research in Brazil
by: Mychael V. Lourenco
Published: (2026)
by: Mychael V. Lourenco
Published: (2026)
Patterns and predictors of cholinesterase inhibitor use in dementia with Lewy bodies
by: Rachel J. Heo, et al.
Published: (2025)
by: Rachel J. Heo, et al.
Published: (2025)
Programmatic research outcomes used to establish the evidence‐base of dementia caregiving support programs: An analysis of Best Programs for Caregiving
by: Morgan J. Minyo, et al.
Published: (2025)
by: Morgan J. Minyo, et al.
Published: (2025)
Modeling amyloid plaque turnover dynamics improves characterization of drug effects
by: Eline van Maanen, et al.
Published: (2025)
by: Eline van Maanen, et al.
Published: (2025)
AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records
by: Sara Knox, et al.
Published: (2025)
by: Sara Knox, et al.
Published: (2025)
Alzheimer's disease drug development pipeline: 2026
by: Jeffrey L. Cummings, et al.
Published: (2026)
by: Jeffrey L. Cummings, et al.
Published: (2026)
Alzheimer's disease drug development pipeline: 2025
by: Jeffrey L. Cummings, et al.
Published: (2025)
by: Jeffrey L. Cummings, et al.
Published: (2025)
Systematic review and meta‐analysis of antipsychotic discontinuation in dementia
by: Sophie Roche, et al.
Published: (2025)
by: Sophie Roche, et al.
Published: (2025)
Awareness and cognitive rehabilitation in Alzheimer's disease and frontotemporal dementia
by: Eric Salmon, et al.
Published: (2024)
by: Eric Salmon, et al.
Published: (2024)
Simulation of Alzheimer's diagnostic flows with blood biomarker test options in Japan
by: Ataru Igarashi, et al.
Published: (2025)
by: Ataru Igarashi, et al.
Published: (2025)
Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains
by: Gregory A. Cary, et al.
Published: (2024)
by: Gregory A. Cary, et al.
Published: (2024)
Care staff perspectives of clinically meaningful outcomes for dementia residents
by: Alaine E. Reschke‐Hernández, et al.
Published: (2025)
by: Alaine E. Reschke‐Hernández, et al.
Published: (2025)
A psychometric study of the Flourishing Scale for people living with dementia
by: Chris Clarke, et al.
Published: (2025)
by: Chris Clarke, et al.
Published: (2025)
Two new positive psychosocial measures for persons living with dementia
by: Sheila L. Molony, et al.
Published: (2025)
by: Sheila L. Molony, et al.
Published: (2025)
Alzheimer's disease drug development in an evolving therapeutic landscape
by: Stacie Weninger, et al.
Published: (2024)
by: Stacie Weninger, et al.
Published: (2024)
Evaluation of racial and ethnic heterogeneity in the associations of sleep quality and sleep apnea risk with cognitive function and cognitive decline
by: Ruijia Chen, et al.
Published: (2024)
by: Ruijia Chen, et al.
Published: (2024)
Evaluating neurotoxicity and AD‐related molecular phenotypes to anticholinergic medications in hiPSC‐derived neurons from the ACT cohort
by: Inez K.A. Pranoto, et al.
Published: (2025)
by: Inez K.A. Pranoto, et al.
Published: (2025)
Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
by: Alan Cronemberger Andrade, et al.
Published: (2025)
by: Alan Cronemberger Andrade, et al.
Published: (2025)
Locus coeruleus alterations in dementia with Lewy bodies: A systematic review
by: Anaëlle Bain, et al.
Published: (2026)
by: Anaëlle Bain, et al.
Published: (2026)
Perspectives on meaningful dementia treatment and care from those with lived experience
by: Walter Moczygemba, et al.
Published: (2025)
by: Walter Moczygemba, et al.
Published: (2025)
Supporting dementia caregivers: The role of “lived experience” and public health collaboration
by: Chelsea Kline, et al.
Published: (2025)
by: Chelsea Kline, et al.
Published: (2025)
Resources for estimating dementia prevalence at the state and local levels in the United States
by: Erin E. Bennett, et al.
Published: (2026)
by: Erin E. Bennett, et al.
Published: (2026)
What is older adults’ understanding of Alzheimer's disease research registries? Findings from 20 focus group studies
by: Litty Samuel, et al.
Published: (2025)
by: Litty Samuel, et al.
Published: (2025)
Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative
by: Pranitha Y. Premnath, et al.
Published: (2024)
by: Pranitha Y. Premnath, et al.
Published: (2024)
A common outcome set for trials in dementia with Lewy bodies (DLB COS)
by: Joseph P. M. Kane, et al.
Published: (2025)
by: Joseph P. M. Kane, et al.
Published: (2025)
Discrepancies between self‐ and proxy‐rated quality of life in people living with dementia
by: Maresa Buchholz, et al.
Published: (2024)
by: Maresa Buchholz, et al.
Published: (2024)
Rural–urban disparities of Alzheimer's disease and related dementias: A scoping review
by: Mackenzie Kramer, et al.
Published: (2025)
by: Mackenzie Kramer, et al.
Published: (2025)
Similar Items
-
Differential Effects of Anticholinergic Medications in Patient hiPSC‐Derived Neurons
by: Tiara A. Schwarze‐Taufiq, et al.
Published: (2024) -
Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
by: Benjamin R. Underwood, et al.
Published: (2025) -
Anti‐epileptic drug use and subsequent degenerative dementia occurrence
by: Naoki Ikegaya, et al.
Published: (2024) -
Vascular cognitive impairment and dementia drug‐development pipeline 2025
by: Ying Xu, et al.
Published: (2026) -
Genetically proxied IL‐6 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: A drug target Mendelian randomization study
by: Evangelos Pavlos Myserlis, et al.
Published: (2024)